bupropion hydrochloride
- Product NDC
- 70377-034
- 11-digit product format
- 703770034
- Labeler code
- 70377
- Product ID
- 70377-034_1976a35a-d4d0-4a6a-b406-1821aba2e6c9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bupropion hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Biocon Pharma Inc.,
- Application
- ANDA211020
- Marketing category
- ANDA
- Marketing start
- 2019-01-28
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70377-034-11 | 70377003411 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70377-034-11) | 2019-01-28 | 0000-00-00 | No | No | Current |
| 70377-034-12 | 70377003412 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70377-034-12) | 2019-01-28 | 0000-00-00 | No | No | Current |
| 70377-034-13 | 70377003413 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70377-034-13) | 2019-01-28 | 0000-00-00 | No | No | Current |